Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
BiomericaBMRA | Open-market buy | 23/05/24–23/05/25 | 23/05/26 | 700 sh2 trades | $1.59avg. | $1,115 | +0.1% | |
BiomericaBMRA | Open-market buy | 23/05/10–23/05/12 | 23/05/12 | 2,200 sh2 trades | $1.19avg. | $2,624 | +0.2% | |
BiomericaBMRA | Open-market buy | 23/05/09 | 23/05/10 | 300 sh | $1.39 | $417 | +0.0% | |
BiomericaBMRA | Open-market buy | 23/05/04 | 23/05/05 | 1,000 sh | $1.36 | $1,360 | +0.1% | |
BiomericaBMRA | Open-market buy | 23/04/27–23/04/28 | 23/05/01 | 4,400 sh2 trades | $1.32avg. | $5,818 | +0.4% | |
BiomericaBMRA | Open-market buy | 23/04/26 | 23/04/27 | 7,000 sh | $1.26 | $8,820 | +0.7% | |
Allen BarbieriExecutive Vice Chairman | BiomericaBMRA | Open-market buy | 23/01/27 | 23/01/31 | 1,538 sh | $2.94 | $4,521.72 | +1.5% |
Catherine CosteDirector | BiomericaBMRA | Open-market buy | 23/01/26 | 23/01/30 | 2,190 sh | $2.96 | $6,482.4 | +5.3% |
BiomericaBMRA | Open-market buy | 23/01/25 | 23/01/26 | 1,800 sh | $2.85 | $5,130 | +0.2% | |
BiomericaBMRA | Open-market buy | 23/01/24 | 23/01/25 | 2,000 sh | $2.81 | $5,620 | +0.2% |